In our watch, the solution to the situation lies in rebalancing the margins of different players in the worth chain by reviewing the costs of such substances, especially by contemplating growing the co-payments granted to these medicines, preparations or substances. This rebalancing would, on one particular hand, make these therapies https://codyjjhez.hamachiwiki.com/808610/article_under_review